NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Can Rheumatoid Arthritis Be Modified with an Anti-inflammatory Diet?on January 23, 2020 at 7:38 am
5 In this study, patients who had their disease for less than 1 year were initiated on triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine and advised to take fish oil supplements ...
- 5 major advances in inflammatory bowel disease (IBD) treatmenton January 23, 2020 at 6:33 am
Lymphoma not associated with anti-TNF therapy in pediatric IBD patients Study title: Low risk of lymphoma in pediatric patients with inflammatory bowel disease treated using anti-tumor necrosis factor ...
- Applied Genetic Slumps Despite Encouraging Data For Gene Therapy To Treat Rare Inherited Visual Disorderon January 23, 2020 at 6:22 am
are tumbling Thursday despite the company reporting encouraging results from an Phase 1/2 study. The Cambridge, Massachusetts-based company released interim results from the dose-escalation cohorts of ...
- Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagyon January 23, 2020 at 1:37 am
Inhibition of autophagy compromised the ability of IVIG to suppress the inflammatory cytokines in innate immune cells. Moreover, IVIG therapy in inflammatory myopathies such as dermatomyositis, ...
- Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agenton January 23, 2020 at 12:38 am
... a rat model of acute dermatitis to investigate the anti-inflammatory effects of ozenoxacin and evaluate the possible contribution of these effects to anti-inflammatory acne therapy. Cytotoxicity ...
- Study shows how gene therapy may help protect against vision loss in multiple sclerosison January 21, 2020 at 7:13 pm
Recurrent episodes of inflammation result in demyelination ... professor of microbiology & physiological systems, director of the UMMS Horae Gene Therapy Center and Viral Vector Core, and co-director ...
- FDA accepts investigational NDA for ulcerative colitis therapyon January 21, 2020 at 2:38 pm
“I am pleased that this promising drug candidate can now move forward with phase 2b testing in the U.S.,” William J. Sandborn, MD, director of the Inflammatory Bowel Disease Center at UC San Diego ...
- Researchers identify a possible cause and treatment for inflammatory bowel diseaseon January 21, 2020 at 7:50 am
Inflammatory bowel disease (IBD) is a category of refractory inflammatory disease ... Because of its complex and refractory character, researchers have focused on determining the detailed pathogenesis ...
- Light therapy for immune cells helps with side effects of cancer therapyon January 21, 2020 at 7:45 am
Researchers from the Medical Center - University of Freiburg and Swiss colleagues have now shown that these reactions can be stopped with a specific light therapy. They treated a 29-year-old cancer ...
via Bing News